• HSD3 Implications of Non-Medical Switching in Medicare Part D: An Updated Review of the Literature

    Jun 1, 2024, 00:00

  • CO150 Efficiacy of Back School Program in Connection with Physical Activity Amongst Hungarian Adolescents

    Jun 1, 2024, 00:00

  • HTA Decisions and Deliberative Processes

    Jun 1, 2024, 00:00

  • MSR97 Indirect Estimation of Post-Distant Recurrence Survival (PDRS) for Resected Stage II/III Melanoma: A Network-Meta Analysis (NMA) Approach

    Jun 1, 2024, 00:00

  • Market Access on Availability and Use of Drugs

    Jun 1, 2024, 00:00

  • MSR103 Optimizing Systematic Literature Reviews in Endometrial Cancer: Leveraging AI for Real-Time Article Screening and Data Extraction in Clinical Trials

    Jun 1, 2024, 00:00

  • RWD168 Fractures in Adults Age Eighty and Older in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • SA60 The Use of Natural Language Processing in Literature Reviews

    Jun 1, 2024, 00:00

  • MSR48 Utilization of High-Dimensional Propensity Score and Targeted Maximum Likelihood Estimation with Machine Learning to Improve Causal Effect Estimation in Patients with Nonvalvular Atrial Fibrillation and Hypertension

    Jun 1, 2024, 00:00

  • EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective

    Jun 1, 2024, 00:00

  • RWD109 The Impact of the out-of-Pocket Cost of Insulin on Healthcare Resource Utilization and All Healthcare-Related Costs Using the Medical Expenditure Panel Survey 2016-2018

    Jun 1, 2024, 00:00

  • HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?

    Jun 1, 2024, 00:00

  • MT5 Comparison of Outcomes of ePTFE Vascular Grafts With Heparin End-Point Covalent Bond and Alternative Autologous Vein for Below-Knee Surgical Bypass Procedures in Critical Limb Ischemia Patients

    Jun 1, 2024, 00:00

  • HPR131 The Risk of Osteoporotic Fractures in Elderly Asthmatic Patients According to Prescribing Patterns of Systemic Corticosteroid in South Korea

    Jun 1, 2024, 00:00

  • RWD18 Healthcare Costs Associated With Type 1 Diabetes in Adults With a Commercial, Medicaid, or Medicare Coverage in US Clinical Practice

    Jun 1, 2024, 00:00

  • Reviewer Acknowledgment

    Jun 1, 2024, 00:00

  • EE10 The Impact of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in Brazil: Results of a Global Survey

    Jun 1, 2024, 00:00

  • PCR136 Development of a Patient Preference Questionnaire Appropriate for Use with Potential Regimens for HIV Cure

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • EPH206 Incidence and Risk Factors for Empiric Treatment Failure Among Females With Uncomplicated Urinary Tract Infections in an Integrated Health Delivery Network

    Jun 1, 2024, 00:00

  • HPR85 Estimating the Income Elasticity of Abortion: A Cross-National Study of 99 Countries

    Jun 1, 2024, 00:00

  • HPR102 Trends in Specialty Pharmacy Use Among US Medicare Beneficiaries: Implications for Part D Policy

    Jun 1, 2024, 00:00

  • Economic Impact of Rare Diseases

    Jun 1, 2024, 00:00

  • CO153 Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

    Jun 1, 2024, 00:00

  • EE331 Clinical and Health Outcomes Associated With Different Treatment Sequences for Moderate-to-Severe Ulcerative Colitis

    Jun 1, 2024, 00:00

  • EPH74 Incidence and Lethality of Adult Pneumonia, Bacteremia, or Meningitis in Colombia From 2015 to 2022: A Retrospective, Database Study

    Jun 1, 2024, 00:00

  • PCR179 Manifestations and Comorbid Conditions Among Patients with Osteogenesis Imperfecta (OI): A US Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH

    Jun 1, 2024, 00:00

  • HPR31 A Targeted Literature Review To Identify the Dimensions of Sustainable Global Biosimilars Markets

    Jun 1, 2024, 00:00

  • P28 Impact of FDA Expedited Review Programs on New Drug Approval Time

    Jun 1, 2024, 00:00

  • Award Winners

    Jun 1, 2024, 00:00

  • EE415 Cost of Hypoglycemia Among Hospitalized Patients With Diabetes Mellitus

    Jun 1, 2024, 00:00

  • MSR19 Methods for Relaxing the Proportional Odds Assumption in Meta-Analysis of Aggregate Data

    Jun 1, 2024, 00:00

  • HTA3 What Are the Reasons for Receiving a Negative Decision from NICE? - A 5-Year Review (2019-2023) of NICE Decisions

    Jun 1, 2024, 00:00

  • HSD122 Medication Adherence, Persistence, and Treatment Switching in Patients Receiving Advanced Therapies for Rheumatoid Arthritis in Clinical Practice

    Jun 1, 2024, 00:00

  • RWD117 Unraveling Disparities in Right Heart Failure: A Comprehensive Analysis of Demographics, Socioeconomic Factors, and Mortality Predictors in a 117,633-Patient Cohort (2017-2020)

    Jun 1, 2024, 00:00

  • EE302 Cost-Utility Analysis of Eptinezumab Versus Erenumab for Episodic Migraine Headaches Patients in the United States

    Jun 1, 2024, 00:00

  • PCR142 Qualitative Insights Into Disease Burden and Meaningful Change Associated With Cutaneous Neurofibromas (CNFs) in Adults With Neurofibromatosis Type 1

    Jun 1, 2024, 00:00

  • EPH173 Estimating the Utilization of Doxycycline Post-Exposure Prophylaxis (DoxyPEP) and the Impact on Syphilis Rates in Colorado

    Jun 1, 2024, 00:00

  • EPH44 Healthcare Expenditures Among Older Adult with Polypharmacy in the United States: A Propensity Score-Matched Cross-Sectional Study

    Jun 1, 2024, 00:00

  • EE120 Economic Burden of Pompe Disease in Colombia

    Jun 1, 2024, 00:00

  • HPR62 Analysis of FDA-Issued Warning Letters for Fraudulent Claims Within the Economic, Clinical, and Humanistic Outcomes (ECHO) Framework

    Jun 1, 2024, 00:00

  • HSD76 A Systematic Literature Review (SLR) to Evaluate the Role of Socioeconomic Factors Associated with Treatment Practices Among Oncology Patients

    Jun 1, 2024, 00:00

  • EE341 A Comparison of Stapling Costs Used in Hybrid vs Robotic Surgery

    Jun 1, 2024, 00:00

  • CO49 Progression of Chronic Kidney Disease Among Older Adults with Hypertension Using Group-Based Trajectory Modeling

    Jun 1, 2024, 00:00

  • EE327 Public Preferences for Improving Health Equity: A Qualitative Focus Group Study

    Jun 1, 2024, 00:00

  • EE55 Medico-Economic Contribution of Multiplex PCR To the Diagnosis of Meningitis

    Jun 1, 2024, 00:00

  • EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • P26 Analyzing Drug Shortages and Pricing: Lessons from Canada

    Jun 1, 2024, 00:00

  • RWD121 Mental Health Outcomes and Treatments Utilized for Postpartum Depression Patients Hospitalized for a Mood Disorder in the US Using Real-World Data

    Jun 1, 2024, 00:00

  • EPH81 Patient Characteristics and Health Care Resource Utilization of Cognitive Impairment Among Patients with Schizophrenia in the Veterans Affairs Administration System

    Jun 1, 2024, 00:00

  • HPR9 Racial and Ethnic Inequities in Endometrial Cancer Survival From 2017 to 2022: Assessing the Influence of Social Determinants of Health

    Jun 1, 2024, 00:00

  • EPH80 Outpatient Transfusions and Occurrence of Febrile Non-Hemolytic Transfusion Reactions Among U.S. Medicare Beneficiaries, Ages 65 and Older, During 2016-2022: Utility of Real-World Data

    Jun 1, 2024, 00:00

  • EE21 Healthcare Resource Utilization Comparison of Balloon-Expandable Valve Versus Self-Expandable Valve for Transcatheter Aortic Valve Replacement in China

    Jun 1, 2024, 00:00

  • EPH45 Survey of Residents’ Perceptions and Concerns on Air Pollution in Maharashtra, India

    Jun 1, 2024, 00:00

  • CO64 Prevalence of Immunosuppressants and Antifibrotic Use in Patients With Connective Tissue Disease-Related Interstitial Lung Disease

    Jun 1, 2024, 00:00

  • EPH165 The Fiscal Costs of a Public Health Crisis: Lessons From Zika in the United States

    Jun 1, 2024, 00:00

  • Methods to Include Environmental Impacts in Health Economic Evaluations and Health Technology Assessments: A Scoping Review [Editor's Choice]

    Jun 1, 2024, 00:00

  • PCR154 Health State Utility Values in COVID-19: A Vignette Study in Japan

    Jun 1, 2024, 00:00

  • HSD88 The Impact of Diagnosing Provider Type on Longitudinal Care for Patients With Newly Diagnosed Huntington’s Disease (HD)

    Jun 1, 2024, 00:00

  • EE351 Economic Evaluation of Botulinum Toxin Type a (XEOMEEN) in the Treatment of Adult Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • HSD27 Patterns of Postoperative Opioid Dispensing for Common Surgical Procedures Among Medicaid Beneficiaries in 2020-2021

    Jun 1, 2024, 00:00

  • CO121 Evaluating Disparities in Clinical Outcomes Among Medicare Beneficiaries With Peripheral Artery Disease (PAD): A Call To Action for Health Equity

    Jun 1, 2024, 00:00

  • CO74 Hospitalizations with Initiation of Hydroxychloroquine in Patients with Heart Failure with Preserved Ejection Fraction and Autoimmune Disease

    Jun 1, 2024, 00:00

  • CO136 Unmet Treatment Needs in the Management of Patients With Eosinophilic Esophagitis: Insights From a Real-world Survey

    Jun 1, 2024, 00:00

  • CO138 Impact of Steroid Withdrawal at Various Time Points After Liver Transplantation on Diabetes Mellitus: A Population-Based Cohort Study in South Korea

    Jun 1, 2024, 00:00

  • MSR29 Application of a Novel Bayesian Dynamic Borrowing Approach Using Anonymized Finnish Real-World Data As an External Control Arm to Augment an Internal Control Arm of a Randomized Clinical Trial

    Jun 1, 2024, 00:00

  • OP12 Exploring Preferences in Selecting Dissertation Topics Among Ph.D. Students in Health Economics and Outcomes Research (HEOR) in the United States

    Jun 1, 2024, 00:00

  • EE71 Understanding Pharmacy Costs and the Changing Treatment Landscape in Huntington's Disease (HD) in the US: A Systematic Literature Review (SLR) and Database Review for Disease-Modifying Therapies (DMT) in Development

    Jun 1, 2024, 00:00

  • EPH30 Real-World Adherence to Glycemic Self-Monitoring and Associated Factors Among Type 2 Diabetes Patients in Algeria: A Descriptive Cross-Sectional Study

    Jun 1, 2024, 00:00

  • MT32 Novel Graft Materials for Lumbar Spinal Fusion Procedures:12 Months Outcomes

    Jun 1, 2024, 00:00

  • EE32 Determining the Expected Pricing Advantage of First-in-Indication and First-in-Class Non-Oncology Orphan Products

    Jun 1, 2024, 00:00

  • EE46 An Early Cost-Effectiveness Analysis of Abelacimab Versus Rivaroxaban, a Standard of Care Direct Oral Anticoagulant (DOAC), in Patients with Atrial Fibrillation Using Preliminary Results from the AZALEA-TIMI 71 Trial

    Jun 1, 2024, 00:00

  • PT27 Changes in the Economic Burden of Breast Cancer Neoplasms in Colombia After the Cancer Control Model

    Jun 1, 2024, 00:00

  • EE194 Health Care Resource Utilization, Total and out of Pocket Expenditures Among Adults with Rheumatoid Arthritis: Medical Expenditure Panel Survey Study

    Jun 1, 2024, 00:00

  • HTA58 HTA Assessment of Single-Arm Trials: Comparison between the HAS and SMC

    Jun 1, 2024, 00:00

  • PCR250 Need for Care in Essential Tremor and the Indirect Burden on Care Partners

    Jun 1, 2024, 00:00

  • EE2 Challenges of Evaluating and Modelling Vaccination for Prevention of Dengue Illness in United Kingdom (UK) Travelers: A Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • PT26 Health Economic Impact of Non-Persistence with Tamoxifen Adjuvant Endocrine Therapy in Pre-Menopausal Women with Early-Stage Breast Cancer: A Simulation Study

    Jun 1, 2024, 00:00

  • EPH228 Disability and Workers’ Compensation Absences Associated With Major Depressive Disorder and the Overlap With Family Medical Leaves Among United States Employees

    Jun 1, 2024, 00:00

  • EE487 Exploring the Healthcare Resource Utilization (HCRU) Associated with Rare Diseases (RD) in the United States (US): A Systematic Literature Review (SLR) across Six Disease Areas

    Jun 1, 2024, 00:00

  • SA38 Adaptation of a Benefit Trade-Off Instrument to Elicit Inequality Aversion in the United States

    Jun 1, 2024, 00:00

  • EE334 The Diagnostic Odyssey and Cost-Effectiveness of Genomic Testing in Indigenous Children in British Columbia, Canada

    Jun 1, 2024, 00:00

  • CO78 Transfusion Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Transfusion-Dependent Beta-Thalassemia: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EPH135 Impact of Demographics and Social Determinants of Health on Hospitalization Costs in US Adults With Respiratory Syncytial Virus

    Jun 1, 2024, 00:00

  • EPH124 Examining the Effect of Hypertension, Type-2 Diabetes Mellitus, Hyperlipidemia, and Obesity on Endometrial Cancer Staging

    Jun 1, 2024, 00:00

  • HPR89 Trends in Hospital Charging Practices from 2019-2022 Among Hospitals with and without Chimeric Antigen Receptor (CAR) T-Cell Therapy Utilization

    Jun 1, 2024, 00:00

  • RWD130 European Health Data Space (EHDS) Requires Secure Processing Environments (SPEs) – Comparison of SPESiOR to Other SPE-Type Environments from Finnish, Nordic, European, and Global Settings

    Jun 1, 2024, 00:00

  • Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues

    Jun 1, 2024, 00:00

  • EPH205 Frequency of Moderate to Severe Atopic Dermatitis and Clinical Characteristics in a Colombian HMO: Results for 2015-2022

    Jun 1, 2024, 00:00

  • CO137 Are Standard Indirect Treatment Comparison Methods Suitable to Compare First-Line Vs Maintenance Therapies? An Assessment of Enfortumab Vedotin + Pembrolizumab Vs Avelumab in Locally Advanced/Metastatic Urothelial Carcinoma

    Jun 1, 2024, 00:00

  • PCR157 Assessment of Patient Reported Outcomes in Chronic Versus Acute Disease: A Comparison of Study Design and Analytic Approaches

    Jun 1, 2024, 00:00

  • OP1 Assessing the Quality and Impact of Patient Engagement: Co-Creation of the Patient Engagement Impact Measurement (PEIM) Framework and Metrics

    Jun 1, 2024, 00:00

  • MSR31 Comparison of Indirect Cost Calculations in Chronic Diseases and Caregivers Using the 2023 US National Health and Wellness Survey

    Jun 1, 2024, 00:00

  • EE463 A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab (NIVO+IPI) Vs Pembrolizumab Plus Axitinib (PEM+AXI) for the First-Line Treatment of Intermediate or Poor (I/P)-Risk Advanced Renal Cell Carcinoma Patients in Peru

    Jun 1, 2024, 00:00

  • EE89 The Economic Impact of Anti-Scorpion Serum in the Management of Scorpion Envenomation in Algeria

    Jun 1, 2024, 00:00

  • MT25 Smartphone-Acquired Patient Reported Outcomes and Wrist-Worn Wearable Device-Acquired Sensing Data in Rheumatoid Arthritis: A Multicenter Single-Arm Prospective Study for Digital Biomarker (INTERIM REPORT)

    Jun 1, 2024, 00:00

  • EPH219 Understanding the Impact of Physical Exercise in People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US (2013-2023)

    Jun 1, 2024, 00:00

  • PCR48 Health-Related Quality of Life for Disease-Modifying Therapies Among Patients With Spinal Muscular Atrophy in Taiwan

    Jun 1, 2024, 00:00

  • EE375 Cost Savings and the Opportunity for Expanded Treatment Access with Increased Use of Biosimilar Adalimumab in the United States

    Jun 1, 2024, 00:00

  • EPH231 HPV Genotyping in Invasive Cervical Cancer Samples from Women Attended at an Oncological Hospital between 2017-2021 in Ecuador

    Jun 1, 2024, 00:00

  • EPH90 Health Characteristics and Adherence Patterns in Electronic Wearable Device Users: A Study in Low- and Middle-Income Countries

    Jun 1, 2024, 00:00

  • PCR64 Examining the Disability Paradox and Health State Utility Valuation in Achondroplasia

    Jun 1, 2024, 00:00

  • MT9 Association of Neighborhood Disparity on Access to Tissue Surgical Heart Valves

    Jun 1, 2024, 00:00

  • EE506 Clinical Consequences and Associated Costs of Treating Patients With Waldenström Macroglobulinemia in the First-Line Setting With Bruton Tyrosine Kinase Inhibitors

    Jun 1, 2024, 00:00

  • RWD55 Comparison of Real-World Outcomes Between a Clinical-Genomics Database and Other Real-World Databases Among Immunotherapy-Treated Patients With Advanced Non-Small Cell Lung Cancer (ANSCLC)

    Jun 1, 2024, 00:00

  • PCR81 Association between Video Gaming Habits and Psychological Distress Among Adolescents

    Jun 1, 2024, 00:00

  • PT42 A Systematic Literature Review and Meta-Analysis Comparing Robotic-Assisted Surgery Using the Da Vinci Surgical Systems for Benign Gynecological Procedures to Laparoscopic or Open Approach

    Jun 1, 2024, 00:00

  • CO123 Socio-Demographics, Clinical Characteristics, and Quality of Life in Patients with Parkinson’s Disease with and without Comorbid Insomnia

    Jun 1, 2024, 00:00

  • MSR96 Real-World Data Integration for Causal Inferen Benefits, Costs, and Case Studies

    Jun 1, 2024, 00:00

  • PCR124 Burden of Fracture and Fracture Management Among Individuals with Osteogenesis Imperfecta: Results from a Survey of Adults and Caregivers

    Jun 1, 2024, 00:00

  • P42 Budget Impact Analysis of Eculizumab Biosimilar for Treatment of Paroxysmal Nocturnal Hemoglobinuria from Public Hospital Perspective in 2023

    Jun 1, 2024, 00:00

  • RWD107 Gender Disparities in the Management of Rheumatoid Arthritis in the US: A Real-World Evidence Study

    Jun 1, 2024, 00:00

  • HPR144 Optimization in Universal Health Coverage Design in South Africa Considering Both Health Outcomes and Health-Induced Poverty Outcomes

    Jun 1, 2024, 00:00

  • CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade

    Jun 1, 2024, 00:00

  • P39 Quantifying Patient Preferences and Healthy-Time-Equivalents for Eosinophilic Esophagitis Treatments: A Stated-Preference Study

    Jun 1, 2024, 00:00

  • MSR98 Prediction of Antipsychotic Associated Weight Gain in Children and Adolescents Taking Second Generation Antipsychotics: A Machine Learning Approach

    Jun 1, 2024, 00:00

  • MT30 Budget Impact of Improved Perioperative Reprocessing of Surgical Sets Used in Trauma Surgery in a Major German University Hospital

    Jun 1, 2024, 00:00

  • HTA17 Cost-Effectiveness Analysis of Capivasertib Plus Fulvestrant in Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2-) Negative Advanced Breast Cancer: A US Payer Perspective

    Jun 1, 2024, 00:00

  • EE477 Reductions in Real-World Healthcare Resource Utilization Among United States Hereditary Angioedema (HAE) Patients Following Berotralstat Initiation

    Jun 1, 2024, 00:00

  • EPH129 Tobacco Product Experien Which Consumer Reported Outcome Measures for Real World Evidence Studies?

    Jun 1, 2024, 00:00

  • OP7 Health and Wellbeing in Teleworking: Exploring Key Factors

    Jun 1, 2024, 00:00

  • EPH200 Epidemiological Disease Burden of Female Infertility Associated with Male Factors Based on Routinely Collected Health Data between 2010-2019

    Jun 1, 2024, 00:00

  • PCR60 Assessment of Quality of Life in Type II Diabetic Patients

    Jun 1, 2024, 00:00

  • EE478 Willingness to Pay Study for Migraine Medications in Argentina

    Jun 1, 2024, 00:00

  • EE495 A Targeted Literature Review of Lung Function Decline in Idiopathic Pulmonary Fibrosis to Improve Survival Predictions in Cost-Effectiveness Analyses

    Jun 1, 2024, 00:00

  • EE482 Building Better Models: A Simulation Case Study Demonstrating the Crucial Role of Ergodicity in Building Robust Markov Chains

    Jun 1, 2024, 00:00

  • EE147 Healthcare Resource Utilization of Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF): A Retrospective Claims Analysis

    Jun 1, 2024, 00:00

  • EPH84 Relationship between the Effectiveness of Municipal Public Health Plans and Programs for the Prevention of Suicide and Suicide Attempts with Their Operational and Financial Performance

    Jun 1, 2024, 00:00

  • EE345 Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis

    Jun 1, 2024, 00:00

  • CO50 Benefit and Risk of Oral Anticoagulant Initiation Strategies in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation Using the SEER-Medicare Database

    Jun 1, 2024, 00:00

  • MSR75 Guidance or Misdirection? Unpacking the Role of Feedback in Health Preference Assessments

    Jun 1, 2024, 00:00

  • PCR58 Subjective Expectations on Having Implanted Medical Devices at Older Ages: Results of a Cross-Sectional Population Survey

    Jun 1, 2024, 00:00

  • PCR41 Exploration on Quality of Life of Caregivers of Patients With Bipolar Affective Disorder

    Jun 1, 2024, 00:00

  • MSR14 Multi-Output Learning for Rare Event Analysis

    Jun 1, 2024, 00:00

  • EE20 Cost Saving Analysis of Implementing Subcutaneous Formulation of Atezolizumab in a Danish Context (CS-ASSIST)

    Jun 1, 2024, 00:00

  • PCR156 The Balancing Act of Paid Work and Caregiving in Duchenne Muscular Dystrophy (DMD): Results From a Cross-Sectional Survey

    Jun 1, 2024, 00:00

  • HTA38 What Is the Value of Reducing the Use of Scarce Biological Resources Such As Donor Organs?

    Jun 1, 2024, 00:00

  • HPR125 Novel Drug Approvals By the U.S. Food and Drug Administration in Rare Diseases: Findings from 2020–2023

    Jun 1, 2024, 00:00

  • HSD63 Trends of Outpatient Medication Adherence Among Patients with Type 2 Diabetes in China

    Jun 1, 2024, 00:00

  • EE155 Budget Impact Analysis: Alteplase for Stroke Treatment in Argentina

    Jun 1, 2024, 00:00

  • HTA2 A Comparison of NICE Timelines for Highly Specialised Technology Submissions and Resubmissions

    Jun 1, 2024, 00:00

  • PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

    Jun 1, 2024, 00:00

  • HTA15 European Health Technology Assessment: Historical Success of European Joint Assessments

    Jun 1, 2024, 00:00

  • PCR253 Knowledge, Attitude, and Practices (KAP) Regarding Vaccination Against Human Papillomavirus (HPV) Among Young People, Caregivers, and Healthcare Professionals (HCPs)

    Jun 1, 2024, 00:00

  • EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • RWD53 An Inflection Point in Real-World Treatment Intensification for Men With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in the United States (US): Results From Patient Chart Reviews

    Jun 1, 2024, 00:00

  • RWD103 Treatment Patterns and Healthcare Resource Utilization Following Initiation of Aripiprazole Lauroxil Using a 1-Day Initiation Regimen

    Jun 1, 2024, 00:00

  • EPH9 Safety Assessment of Nirmatrelvir-Ritonavir in the FDA Adverse Event Reporting System: A Data Mining Approach

    Jun 1, 2024, 00:00

  • MT34 The Impact of the Use of a Digital Diabetes Management Application on HCRU-Related Costs and Pharmacy Claims in Patients With Type 2 Diabetes Mellitus

    Jun 1, 2024, 00:00

  • HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: An Interrupted Time Series Analysis

    Jun 1, 2024, 00:00

  • HPR95 Why It Is Important to Ensure the Price Is Right: Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jun 1, 2024, 00:00

  • CO114 Clinical Characteristics, Diagnosis, and Impact on Employment in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Canada

    Jun 1, 2024, 00:00

  • HPR84 Variation in Commercial Coverage of Accelerated Approval Drugs

    Jun 1, 2024, 00:00

  • CO3 Prediction of Long-Term Factor IX Durability Among Hemophilia B Patients Treated with Fidanacogene Elaparvovec Gene Therapy

    Jun 1, 2024, 00:00

  • MSR26 Exploring the Validity of Non-Responders As a Surrogate for Treatment Comparator Survival Outcomes in the Context of Histology Independent Therapies

    Jun 1, 2024, 00:00

  • HTA55 USA Vs. Global Pharmaceutical Launches: What Are the Potential Reasons That Can Result in a Pharmaceutical Not Being Commercialized Outside the USA?

    Jun 1, 2024, 00:00

  • RWD133 Postoperative Outcomes of Patients Undergoing Rotator Cuff Repair With Osteoporosis: A TriNetX Database Study

    Jun 1, 2024, 00:00

  • P7 Costs and Health Care Resource Utilization Associated with Negative Symptoms Among Patients with Schizophrenia in the United States

    Jun 1, 2024, 00:00

  • CO71 Characterization of Physician-Reported Outcomes of People with HIV Switching Treatment: Findings from a Real-World Survey in the United States

    Jun 1, 2024, 00:00

  • HTA80 Impact of Restricted EU Market Access Decisions on Patient Access To Medicines in Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE9 Economic Burden of Gaucher Disease in Colombia

    Jun 1, 2024, 00:00

  • RWD157 Objective Fit-4-Purpose Assessment of Real-World Data for Evidence Generation in Type 2 Diabetes Mellitus: A Trial Tokenization Approach

    Jun 1, 2024, 00:00

  • EPH27 The Efficacy of Interventions Utilized in Communicating Risk Information to Improve Behavioral Outcomes Among Individuals Who Are Genetically Predisposed of Type 2 Diabetes: A Systematic Review

    Jun 1, 2024, 00:00

  • SA47 A Systematic Literature Review and Pooled Rates Analysis of Heart Failure Trials in the US

    Jun 1, 2024, 00:00

  • EE163 Impact of Slowing Alzheimer’s Disease (AD) Progression: A Simulation Model in a Population of Patients with Early AD in the United States

    Jun 1, 2024, 00:00

  • EE353 An Analysis of Stakeholders’ Contribution to High-WAC and Low-WAC Adalimumab Products in 2025 Under the Inflation Reduction Act in the United States

    Jun 1, 2024, 00:00

  • EE264 Cost-Effectiveness of GLP-1 Medications in Non-Diabetic Obesity Population

    Jun 1, 2024, 00:00

  • EE69 Estimating a Drug's Price After Loss of Exclusivity As a Function of the Cost of Goods Sold

    Jun 1, 2024, 00:00

  • PCR235 Study of the Dietary Habits and Quality of Life of People with Phenylketonuria

    Jun 1, 2024, 00:00

  • Advancing the Use of Patient Reported Outcomes

    Jun 1, 2024, 00:00

  • EE26 Economic Burden of Acquired Hemophilia- A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE253 An Evaluation of the Prevalence of Diagnosed Opioid Use Disorder and the Economic Burden of Opioid Use Disorder–Related Healthcare Costs in the United States

    Jun 1, 2024, 00:00

  • The Value of the Quality-Adjusted Life Years

    Jun 1, 2024, 00:00

  • EPH147 Socioeconomic Burden of Ischemic Heart Diseases in the Japanese Healthcare System – A System Dynamics Simulation for Policy Decision-Making

    Jun 1, 2024, 00:00

  • HTA51 Machine Learning Approaches to Reduce Economic Impact of Effective Interventions

    Jun 1, 2024, 00:00

  • EPH34 Changes in the Epidemiological Burden of Breast Neoplasms in Colombia After the Cancer Control Model

    Jun 1, 2024, 00:00

  • EE6 Healthcare Resource Utilization and Costs Associated With a Peptide-Based Enteral Formula With Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care

    Jun 1, 2024, 00:00

  • EE369 Healthcare Resource Utilization Among Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada

    Jun 1, 2024, 00:00

  • SA1 Methods for Incorporating Non-Randomized Evidence From Single-Arm Trials Into Network Meta-Analysis (NMA): A Case Study in Recurrent/Metastatic Head and Neck Cancer (R/M-HNSCC)

    Jun 1, 2024, 00:00

  • EPH64 Assessing the Relationship Between Pain Intensity and Health Status Among Older US Adult Opioid Users With Pain

    Jun 1, 2024, 00:00

  • HSD13 Missed Opportunities for Respiratory Disease Diagnosis in the United States During Endemic Spread of SARS-CoV-2

    Jun 1, 2024, 00:00

  • CO81 Cyclosporine Ophthalmic Solution 0.09% Improves the Signs and Symptoms of Dry Eye Disease in Patients Whose Disease Is Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%

    Jun 1, 2024, 00:00

  • EE287 Annual Treatment Cost of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • MSR101 A Novel Methodology for Assessing Response to Lymphoma Treatment in Real-World Studies – the Real-World Lugano (RWLUGANO) Study

    Jun 1, 2024, 00:00

  • EE290 Targeted Literature Review of Cost-Effectiveness Models in Relapsed/Refractory Follicular Lymphoma

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • PCR107 Health-Related Quality of Life and Utility Values Among Patients With Anxiety and/or Depression in a Low-Income Tertiary Care Setting: A Cross-Sectional Analysis

    Jun 1, 2024, 00:00

  • EE441 Cost-Effectiveness of a Comprehensive Team-Based Intervention for Pregnant Women with Diabetes: A Markov Cohort Study

    Jun 1, 2024, 00:00

  • EE88 Cost-Effectiveness of Apixaban Compared to Warfarin, Dabigatran and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation: Results for High-Risk Patient Subgroups Based on the Aristophanes Real-World Evidence Study

    Jun 1, 2024, 00:00

  • MSR35 Item Performance and Structural Validity of the Quick Motor Function Test Among Late Onset Pompe Disease Patients

    Jun 1, 2024, 00:00

  • RWD184 Impact of Cardiovascular Medications on Non-Traumatic Amputation Rates in Type 2 Diabetes: Insights from a Large-Scale Retrospective Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EPH43 Systematic Review of Real-World Data: Assessing Cancer, Major Adverse Cardiovascular Events, Venous Thromboembolism, Infection, and Mortality Risk Associated With Jak Inhibitors in Rheumatoid Arthritis Patients in the United States

    Jun 1, 2024, 00:00

  • CO82 Bayesian Pan-Tumor Multilevel Meta-Regression: An Unanchored Indirect Treatment Comparison (ITC) of Adagrasib Versus Sotorasib in Previously Treated KRASG12C-mutated Advanced/Metastatic Solid Tumors

    Jun 1, 2024, 00:00

  • HTA28 Comparative Analysis of Orphan Drug HTA Assessment: Perspectives from HAS and SMC

    Jun 1, 2024, 00:00

  • PCR195 Assessing Time Trade-Off Utilities in Health States of Chronic Rhinosinusitis with Nasal Polyps: A Pilot Study in Brazil

    Jun 1, 2024, 00:00

  • RWD88 Exploring Patient Characteristics and Treatment in Real-World Endometrial Cancer Patients Users of Platinum Therapy

    Jun 1, 2024, 00:00

  • CO58 Disease- and Glucocorticoid-Related Comorbidities in Classic Congenital Adrenal Hyperplasia: A Claims-Based Retrospective Cohort Analysis

    Jun 1, 2024, 00:00

  • RWD96 Risk of Venous Thromboembolism with Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review

    Jun 1, 2024, 00:00

  • RWD42 Epidemiology, Healthcare Resource Utilization, and Costs of Ulcerative Colitis and Crohn's Disease Patients in Taiwan: A National Health Insurance Research Database (NHIRD) Study

    Jun 1, 2024, 00:00

  • CO188 Fit-for-Purpose and Scalable Strategy to Address Mortality Completeness for Oncology Research: Comparison of Multiple Real-World Sources with the National Death Index

    Jun 1, 2024, 00:00

  • EE364 Cost-Effectiveness of Artificial-Intelligence Enabled Kidney Disease Risk Stratification in US Veterans With Early-Stage Diabetic Kidney Disease

    Jun 1, 2024, 00:00

  • RWD38 The Use of Patient-Generated Functional Outcome Measures in Trials Seeking to Show Improvements in Negative Symptoms or Cognitive Impairment Associated with Schizophrenia

    Jun 1, 2024, 00:00

  • EPH156 Multimorbidity and Its Associations with Adverse Cardiovascular Events and Healthcare Costs Among Patients with Atherosclerotic Cardiovascular Disease: A Real-World Evidence Study

    Jun 1, 2024, 00:00

  • HPR140 Are North Americans Willing-to-Pay More for Life and Limb?

    Jun 1, 2024, 00:00

  • MT43 The Economic Impact of Screening Mammogram Image Quality-Related Retakes and Recalls: A Modeling Study from the Provider Perspective

    Jun 1, 2024, 00:00

  • RWD186 Economic Evaluation of Biosimilar Market in the US: Insights From a Real-World Analysis Using De-Identified Market Clarity Database

    Jun 1, 2024, 00:00

  • PCR169 Drivers of Depression and Anxiety in US Non-Segmental Vitiligo Patients

    Jun 1, 2024, 00:00

  • EPH32 Behaviors and Characteristics of Current and Previous Users of Glucagon-like Peptide-1 Receptor Agonists (GLP-1) in an Online Health Community

    Jun 1, 2024, 00:00

  • CO69 Burden of Clinical Syndromes Associated with Pneumococcal Disease in Ecuador: A 2019 Perspective

    Jun 1, 2024, 00:00

  • CO24 Examination of the Effectiveness of a Shoulder Stabilization Programme Among Throwing Athletes

    Jun 1, 2024, 00:00

  • EPH144 Exploring the Effectiveness and Engagement of Local Communities in Maternity Care Models for Women with Refugee and Migrant Backgrounds and Its Impact on Enhancing Perinatal Health Outcomes: A Comprehensive Systematic Review

    Jun 1, 2024, 00:00

  • OP3 The Upgrade of Educational System for Improving Practical Skills of Economics Graduate Students in HTA in Ukraine

    Jun 1, 2024, 00:00

  • HSD103 Burden of Disease in Patients With Uncontrolled Gout in the USA

    Jun 1, 2024, 00:00

  • PT5 Impacts of National Drug Price Negotiation on Type 2 Diabetes Drugs Price, Volume, and Spending in China

    Jun 1, 2024, 00:00

  • CO15 The Hungarian Nurses Knowledge about Palliative Care

    Jun 1, 2024, 00:00

  • EPH187 Examinating the Safety of Recently Approved Drugs for Cardiovascular Disease Using A Large Database

    Jun 1, 2024, 00:00

  • EE80 The Health Equity Impact of a Hypothetical Disease-Modifying Treatment for Alzheimer's Disease in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • PCR97 Consequences of Misdiagnosed Opsoclonus Myoclonus Ataxia Syndrome (OMAS)

    Jun 1, 2024, 00:00

  • MT7 Measures of ‘Life-Sustaining Medical-Technology’ for Caregivers of Children with Medical Complexity (CO-CMC)

    Jun 1, 2024, 00:00

  • EPH230 County-Level Social Vulnerability Is Associated With Lower Pneumococcal Vaccine Uptake Among Medicare Beneficiaries in the United States (2016-2019)

    Jun 1, 2024, 00:00

  • Table of Contents

    Jun 1, 2024, 00:00

  • EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments

    Jun 1, 2024, 00:00

  • EE131 Cost Savings Associated With Use of 3D Heads-up Display (3D-HUD) in Macular Hole Surgeries: An Academic Hospital Perspective

    Jun 1, 2024, 00:00

  • P32 Effective Data Visualization Techniques for Presenting Scenario Analysis Results in Health Economic Models

    Jun 1, 2024, 00:00

  • EE247 Budget Impact of Infliximab Subcutaneous from the US Healthcare Perspective

    Jun 1, 2024, 00:00

  • RWD22 Utilizing Optum® Market Clarity Dataset for Analyzing Treatment Patterns and Clinical Outcomes in Diabetes: A Propensity Score Matched Study Comparing Gender Cohorts

    Jun 1, 2024, 00:00

  • CO22 Health-Related Quality of Life from a Phase 4 Global Clinical Study to Evaluate Discontinuation and Rechallenge of Pexidartinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib

    Jun 1, 2024, 00:00

  • RWD125 Evaluation of the Case-Mix-Index of Hungarian One-Day Surgical Treatment

    Jun 1, 2024, 00:00

  • SA42 Cognitive Impairment and Cardiovascular Disease in Older Adults: An Evaluation Using Pooled Observational Data

    Jun 1, 2024, 00:00

  • EPH46 Prognostic and Risk Factors of Psoriatic Arthritis Among Adult Psoriasis Patients in the United States: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • HSD33 Contraceptive Use Among Female Patients Who Underwent Bariatric Surgery in the U.S. Commercial Insurance Plans

    Jun 1, 2024, 00:00

  • EPH50 Characterizing the Prevalence of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Among Adults ≥65 Years of Age in the United States (US) Using Three Real-World Cohorts

    Jun 1, 2024, 00:00

  • EE81 Cost-Effectiveness Analysis of Pegmolesatide Compared to Darbepoetin in Patients With Anemia Caused by Chronic Kidney Disease: The Case of China

    Jun 1, 2024, 00:00

  • MSR73 Lessons Learned from Confounder Identification: Insights from German HTA Procedures

    Jun 1, 2024, 00:00

  • PCR116 Knowledge about Osteoporosis and Risk of Consequent Bone Fracture Among the Elderly People

    Jun 1, 2024, 00:00

  • RWD126 Evaluation of the Importance of One-Day Surgical Treatment in Benign Gynecological Surgeries

    Jun 1, 2024, 00:00

  • PCR11 The Impact and Burden of Visual Impairment in Patients With Dry Age-Related Macular Degeneration Relative to Older Adults Without Major Eye Conditions: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • SA43 Potential for Drug Development Using Artificial Intelligence and Machine Learning

    Jun 1, 2024, 00:00

  • EE524 Economic Evaluation of Pronase Granules for Gastric Cancer Screening in High-Risk Population in China

    Jun 1, 2024, 00:00

  • HTA32 Augmenting Health Economic Evidence Analysis: The Synergistic Role of AI in Deductive, Abductive Reasoning, and Insight Generation

    Jun 1, 2024, 00:00

  • P14 Health Equity Impacts of Alteplase for Ischemic Stroke in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • CO21 Association between Pregnant Cigarette Smoking and Offspring Birthweight Using Oracle EHR Real-World Data

    Jun 1, 2024, 00:00

  • EPH28 Public Health Impact of Switching From a 13-Valent to a 15-Valent Pneumococcal Conjugate Vaccine in the Chilean National Immunization Program

    Jun 1, 2024, 00:00

  • RWD51 The Added Value of Linking Real-World Data Sources

    Jun 1, 2024, 00:00

  • HSD18 Patients' Perceptions of Safety of the Health Care in a Large Hospital Institution in Barranquilla, Colombia

    Jun 1, 2024, 00:00

  • EE241 JAV-RARAS: Microscopic Analysis of Patients with Familial Amyloidotic Polyneuropathy in Brazil

    Jun 1, 2024, 00:00

  • PCR129 Indirect Effects of Music Therapy for Aphasia

    Jun 1, 2024, 00:00

  • PCR205 Qualitative Analysis of Twitter Data on Attitudes of Men Who Have Sex with Men Related to Long Acting Injectable Prep

    Jun 1, 2024, 00:00

  • HSD126 Diagnosing Rare Diseases: Referral Behaviors of Physicians in the United States

    Jun 1, 2024, 00:00

  • CO17 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Immuno-Oncology (IO) for First-Line (1L) Esophageal Squamous Cell Carcinoma (ESCC) in Adult Patients

    Jun 1, 2024, 00:00

  • EE347 JAV-RARAS: Preliminary Results of Measuring Adherence to the Phenylketonuria Treatment Protocol in Brazil

    Jun 1, 2024, 00:00

  • HPR138 A Non-Representative Sample: Racial and Ethnic Diversity in Clinical Trials of FDA-Approved Drugs

    Jun 1, 2024, 00:00

  • HPR83 The Distribution and Influential Factors Analysis of National Price-Negotiated Drugs in Medical Institutions and Pharmacies in China: A Case Study of Hyperkalemia

    Jun 1, 2024, 00:00

  • MSR55 Predictive Horizons: Unveiling Cardiovascular Insights With Conditional Inference Trees

    Jun 1, 2024, 00:00

  • PCR80 Make Her Voice Count: Understanding the Use of Patient-Reported Outcomes in Contraceptive Trials

    Jun 1, 2024, 00:00

  • CO16 Shared Identity and Patient Care: Examining Racial and Gender Concordance on Treatment and Testing Adherence in CML

    Jun 1, 2024, 00:00

  • CO154 Prevalence of Unmet Social Needs and Post-Transplant Outcomes Among Adult Sickle Cell Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

    Jun 1, 2024, 00:00

  • P54 Evaluating ChatGPT's Efficacy and Efficiency in the Risk of Bias Assessment in Health Economic Evaluations: A Comparative Analysis Using the Drummond Checklist

    Jun 1, 2024, 00:00

  • HPR118 Are We Closing the Gap? A Review of Health Equity Focused Interventions Along the Liver Cancer Care Cascade in the US

    Jun 1, 2024, 00:00

  • HSD38 Factors Influencing Willingness To Utilize the Emergency Department Among Individuals Living With Sickle Cell Disease

    Jun 1, 2024, 00:00

  • EPH85 Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiovascular Events (MACE) Among Hospitalized Patients With Blood Cancers

    Jun 1, 2024, 00:00

  • CO211 Gout Epidemiology, Pharmacotherapy, Healthcare Utilization, and Outcomes for United States Veterans Affairs Patients From 2016 to 2022

    Jun 1, 2024, 00:00

  • PCR128 Sustainable Food Consumption Patterns Among Adults in Hungary

    Jun 1, 2024, 00:00

  • MSR68 Variability and Improvements of Answers Generated with Different Versions of Large Language Models

    Jun 1, 2024, 00:00

  • EPH121 Prevalence and Correlates of Alcohol Use Disorder Diagnosis Among Cancer Survivors in the United States: Insights From a Real-World Study

    Jun 1, 2024, 00:00

  • MSR54 Estimating Drinking Trajectories in the United States From Adolescence to Old Age: A Three-Step Approach

    Jun 1, 2024, 00:00

  • EE430 Does One Comparator Fit All Scenarios? An Example from the Institute for Clinical and Economic Review’s 2023 Assessment of Relapsing-Remitting Multiple Sclerosis

    Jun 1, 2024, 00:00

  • RWD78 The Relationship of PROMIS Physical Function Scores, Healthcare Resource Utilization, and Charges in Patients Treated for Chronic Mechanical Low Back Pain

    Jun 1, 2024, 00:00

  • HTA24 Adopting a Societal Perspective in Health-Economic Evaluation: A Review of 9 HTA Methodological Guidelines on How to Integrate Societal Costs

    Jun 1, 2024, 00:00

  • EE125 Evaluating the Impact of Hybrid Closed-Loop Systems (HCLS) on Healthcare Utilization and Costs Compared to Standard of Care Therapy Among Patients with Type 1 Diabetes New to Pump Therapy

    Jun 1, 2024, 00:00

  • MSR92 Quantitative Bias Analysis Under the Marginal Structural Modelling Framework

    Jun 1, 2024, 00:00

  • EE138 Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: A Conceptual Framework

    Jun 1, 2024, 00:00

  • CO96 Evidence Gap Analysis of the Burden of Illness and Treatment of Thyroid Eye Disease

    Jun 1, 2024, 00:00

  • CO184 A Matching-Adjusted Indirect Comparison of Centanafadine Vs Lisdexamfetamine, Methylphenidate, and Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: Long-Term Safety and Efficacy Outcomes

    Jun 1, 2024, 00:00

  • RWD32 Advanced Prostate Cancer Decision Support through C PREFS (CANCER PREFERENCE REFLECTION AND ELICITATION FOR FAMILY SUPPORT)

    Jun 1, 2024, 00:00

  • MT11 Innovation in the Pharmaceutical Market: An Analysis of the Patents of Monoclonal Antibodies

    Jun 1, 2024, 00:00

  • EE527 Is List Price the Key Driver of ICER Assessments? Exploring Drivers of Cost-Effectiveness

    Jun 1, 2024, 00:00

  • EE28 Value of Knowing Risk of Developing Neurodegenerative Disease: A Discrete Choice Experiment

    Jun 1, 2024, 00:00

  • MSR77 Incorporating Cure Effect into Copula Models for Long-Term Survival Projections: A Case Study in Previously Treated Advanced Esophageal Squamous Cell Carcinoma (aESCC)

    Jun 1, 2024, 00:00

  • HPR136 Geographic Trends in Chimeric Antigen Receptor (CAR) T-Cell Therapy Access and Utilization

    Jun 1, 2024, 00:00

  • PCR140 Psychometric Validation of the QOL-B Respiratory Domain in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

    Jun 1, 2024, 00:00

  • PT34 Assessment of Direct, Indirect, and Intangible Costs of Rheumatoid Arthritis in Patients Receiving Biological Therapy in Morocco: Ecoram Study

    Jun 1, 2024, 00:00

  • MSR82 Implementation and Validation of the Use of N-Gram Models for Classifying Social Determinants of Health Status from Real World Unstructured Clinical Notes

    Jun 1, 2024, 00:00

  • MSR65 The Benefits of a Complex Identification and Stratification Model for Depression: Insights from a Large Claims Analysis Study

    Jun 1, 2024, 00:00

  • Critical Comments by Food and Drug Administration Reviewers on Patient-Reported Outcomes in Food and Drug Administration Regulatory Submissions (2018-2021) [Editor's Choice]

    Jun 1, 2024, 00:00

  • RWD172 Healthcare Utilization and Costs Among Patients With Episodic Migraine Initiating Galcanezumab Versus Rimegepant for Migraine Prevention in the United States

    Jun 1, 2024, 00:00

  • P31 Improving Long-Term Survival Assessment in Cost-Effectiveness Analyses: Examining Excess Hazard Methods and Cure Models in Non-Small Cell Lung Cancer Study

    Jun 1, 2024, 00:00

  • RWD111 Implementing a Pilot Chart Abstraction Period Improves the Overall Accuracy Rate in Chart Abstraction

    Jun 1, 2024, 00:00

  • EE259 Care-Seeking Pattern and Costs of Health Services in Individuals with Multiple Chronic Conditions

    Jun 1, 2024, 00:00

  • RWD174 Health Care Resources Associated with Clinical Pneumonia, Bacteremia or Meningitis in Colombian Adults: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • EE325 Cost-Effectiveness Analyses of Immune Checkpoint Inhibitors in Renal Cell Carcinoma: A Scoping Review

    Jun 1, 2024, 00:00

  • PT21 A Generalized Framework for Eliciting Unreported Subgroup-Specific Events and Survival Outcomes from Aggregate Level Data: Analyses Advanced Stage Gastrointestinal Cancers

    Jun 1, 2024, 00:00

  • OP20 Objective Measurement of Quality of Life: First Results of the Project "Machine Intelligence for the Objective Determination of Individual Quality of Life" - MI-Lq

    Jun 1, 2024, 00:00

  • EE442 Impact of Benralizumab on Asthma and COPD Exacerbation-Related Healthcare Resource Utilization in Patients with Asthma and Concomitant COPD

    Jun 1, 2024, 00:00

  • Patient-Centered Research

    Jun 1, 2024, 00:00

  • CO30 Comparative Genitourinary Safety of in-Class Sodium Glucose Co-Transporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction

    Jun 1, 2024, 00:00

  • EPH61 Timing of SGLT2 Inhibitor Initiation and Hospital Readmission in Acute Heart Failure With Type 2 Diabetes: A Target Trial Emulation Cohort Study

    Jun 1, 2024, 00:00

  • MSR102 Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis Comparing Binomial and Multinomial Approaches

    Jun 1, 2024, 00:00

  • EPH132 Adverse Drug Reaction-Related Hospital Admission in Older Australians With Dementia

    Jun 1, 2024, 00:00

  • HPR2 The Use of Performance-Based Agreements in Common Diseases in EU3 and US

    Jun 1, 2024, 00:00

  • P50 Increasingly Stringent Clinical Responses and the Association with Improvements in Pain, HRQoL, and Work Productivity in Patients with Hidradenitis Suppurativa: 16-Week Results from Phase 3 Studies BE HEARD III

    Jun 1, 2024, 00:00

  • EPH77 Identifying the Characteristics of Tramadol Usage Among West Virginians

    Jun 1, 2024, 00:00

  • PCR165 Health-Related Quality of Life of Type 1 Diabetes and Severe Hypoglycemia in Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • PCR57 The Dara Project: Assessing Health and Well-Being Measures in Economically Disadvantaged Families

    Jun 1, 2024, 00:00

  • EE492 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease in Colombia

    Jun 1, 2024, 00:00

  • P20 Cardioprotective Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Early Breast Cancer Following Anthracycline- or Trastuzumab-Based Chemotherapy

    Jun 1, 2024, 00:00

  • HTA34 Cost-Effectiveness Analysis of Icosapent Ethyl (IPE) for the Reduction of the Severe Hypertriglyceridemia (HTG) in China

    Jun 1, 2024, 00:00

  • EPH16 Changes in Neutropenia Outcomes Following Implementation of the Clozapine Risk Evaluation and Mitigation Strategy Update

    Jun 1, 2024, 00:00

  • RWD155 Real-World Treatment Patterns Among Adult Patients with Advanced Non-Small Cell Lung Cancer in the US

    Jun 1, 2024, 00:00

  • PCR252 Assessing Treatment Preference in Pediatric Growth Hormone Deficiency: Challenges and Proposed Solutions

    Jun 1, 2024, 00:00

  • EE288 Decision Model to Evaluate the Cost of Clinical Events Associated with Switching from Apixaban to Rivaroxaban Among Patients with Non-Valvular Atrial Fibrillation in Germany

    Jun 1, 2024, 00:00

  • HTA62 Understanding the Disconnect: Characterizing Trends in Inclusion of Family and Informal Caregiver Spillover in US Value Assessments

    Jun 1, 2024, 00:00

  • PCR138 Physiotherapy of Knee Osteoarthritis with Mechanical Traction in a Nuremberg Suspension Grid

    Jun 1, 2024, 00:00

  • PCR32 Comparison of Quality of Life Based on Sociodemographic and Surgical Data Among Total Hip Arthroplasty Patients in Hungary

    Jun 1, 2024, 00:00

  • EE490 Utilization and Costs of Patients With Type-2 Diabetes and Cardiovascular Disease Treated With Sodium Glucose Cotransporter-2 Inhibitors and Glucagon Like Peptide-1 Receptor Agonists

    Jun 1, 2024, 00:00

  • EE388 Economic Evaluation and Budget Impact of Brigatinib Versus Other ALK-Inhibitors for First-Line ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Treatment in the Brazilian Private Healthcare System

    Jun 1, 2024, 00:00

  • EE56 Bearing the Brunt: Disproportionate Burden Among Female Parent-Caregivers in Rare Disease

    Jun 1, 2024, 00:00

  • SA53 Does Mode Matter? Impact of Survey Administration Mode on Health-Related Contingent Valuation: Face-to-Face and Telephone Interviews

    Jun 1, 2024, 00:00

  • EE132 Economic Outcomes and Real-World Adherence of Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises Treated With L-Glutamine, Voxelotor, and Crizanlizumab in the United States

    Jun 1, 2024, 00:00

  • CO167 Type of Pre-Existing Chronic Conditions and Their Associations with Merkel Cell Carcinoma Treatment: Prediction and Interpretation Using Machine Learning Methods

    Jun 1, 2024, 00:00

  • HSD34 Analysis of Changes in the Number of Cases of Gynecological Surgeries for Benign Indications in Hungary

    Jun 1, 2024, 00:00

  • SA56 Disease Severity Is Associated With Poorer Quality of Life Outcomes and Higher Costs in Thyroid Eye Disease (TED): Evidence From Systematic Literature Reviews (SLRs)

    Jun 1, 2024, 00:00

  • CO26 Targeted Literature Review Exploring Burden of Disease in Junctional and Dystrophic Epidermolysis Bullosa

    Jun 1, 2024, 00:00

  • PCR93 Assessment of Prior Experience With Pharmacists and Perceptions of Pharmacists’ Education and Training on Metabolic Syndrome (MetS) Patients’ Willingness to Accept Pharmacist-Provided Services

    Jun 1, 2024, 00:00

  • PCR134 Psychometric Properties of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Analysis of Phase 2 CARTITUDE-2 Study Cohorts A, B, and C

    Jun 1, 2024, 00:00

  • PT10 Utility of the ISPOR Presentations Database to Support the Centers for Medicare and Medicaid Services (CMS) Drug Price Negotiation (DPN): An Apixaban and Rivaroxaban Case Study

    Jun 1, 2024, 00:00

  • CO91 Systemic Therapy Eligibility Criteria of the International Psoriasis Council (IPC) May Reduce Undertreatment of PsO Patients with Low Body Surface Area Involvement Associated with High Disease Burden

    Jun 1, 2024, 00:00

  • SA65 Healthcare Resource Utilization Following 6 Months of Treatment With Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia or Bipolar I Disorder

    Jun 1, 2024, 00:00

  • HSD49 U.S. Real-World Biosimilar Adoption By Specialty Therapeutic Area

    Jun 1, 2024, 00:00

  • HTA78 Strategic Roadmap for Successful Market Penetration in the Dynamic Central and Eastern Europe: Prospect for US/Global Companies?

    Jun 1, 2024, 00:00

  • RWD192 Real-World Use of Tirzepatide Among People Without Evidence of Type 2 Diabetes: Results From Merative Marketscan Commercial Database

    Jun 1, 2024, 00:00

  • Healthcare Resource Utilization and Cost Burden of Selected Chronic Conditions

    Jun 1, 2024, 00:00

  • PCR206 Comparison of the Measurement Properties of EQ-5D-Y-3L and CHU-9D Among Chinese High School Students with Myopia

    Jun 1, 2024, 00:00

  • EPH197 Characterization of Adult Patients With Primary Chronic Immune Thrombocytopenia Using US Administrative Claims Data

    Jun 1, 2024, 00:00

  • HTA11 Manufacturer Engagement and Revision Outcomes in the “Phase Contradictoire” of the HTA Process in Fran A Descriptive Analysis

    Jun 1, 2024, 00:00

  • MT46 Patient Experience and Outcomes with Post-Surgical Remote Monitoring for Patients with Total Knee Arthroplasty (TKA)

    Jun 1, 2024, 00:00

  • HTA31 Analyzing Indirect Treatment Comparisons in Eunethta Assessments: Lessons Learned for the Implementation of EU Joint Clinical Assessments?

    Jun 1, 2024, 00:00

  • EPH88 Pregnancy and Perinatal Outcomes Following Exposure to Medications for Opioid Use Disorder: An Analysis of FAERS (FDA Adverse Event Reporting System)

    Jun 1, 2024, 00:00

  • HPR111 Disease Burden and Medical Insurance Expenditure of National Price-Negotiated Drugs for Multiple Sclerosis Under Dual-Channel Model in China: A Budget Impact Model

    Jun 1, 2024, 00:00

  • HTA35 Selection of Appropriate Endpoints for the EU JCA and National Assessments in Select Member States and England for ATMPs

    Jun 1, 2024, 00:00

  • MSR104 Use of Stochastic Search Variable Selection for Dimension Reduction in Large NMAs

    Jun 1, 2024, 00:00

  • EE104 Value Assessment of Emerging Treatments for Nonalcoholic Steatohepatitis: Lessons from Institute for Clinical and Economic Review Evaluations

    Jun 1, 2024, 00:00

  • EPH127 Association of Marijuana Use With Poor Mental Health Among Non-Institutionalized Adults in the US

    Jun 1, 2024, 00:00

  • Multidimensional Thresholding for Individual-Level Preference Elicitation

    Jun 1, 2024, 00:00

  • RWD119 A Methodological Approach Using Sentiment Analysis of Online Medical Platforms As a Real-World Data Source of Patient Experiences

    Jun 1, 2024, 00:00

  • EPH58 Changes in the Number of Different Categories of Specialists in Europe

    Jun 1, 2024, 00:00

  • MT42 Evaluation of a Novel Single-Use Ureteroscope: User Satisfaction Comparison Survey

    Jun 1, 2024, 00:00

  • PT23 Is a Large Language Model (LLM) More Accurate Than Human Researchers in Correctly Identifying Diseases in Biomedical Abstracts? A Pilot Study

    Jun 1, 2024, 00:00

  • EE484 Clinical and Healthcare Resource Burden of Disease in Patients With Lennox-Gastaut Syndrome (LGS): Results From a US Claims Matched-Control Analysis

    Jun 1, 2024, 00:00

  • HTA41 Analysis of Intensity of Use of Real-World Data in Single Technology Appraisals of Cancer Drugs By the National Institute for Health and Care Excellence

    Jun 1, 2024, 00:00

  • CO200 Gender Differences in Clinician-Recorded Side Effects Among People With First Episode Psychosis: Real-World Evidence From Electronic Health Record Data

    Jun 1, 2024, 00:00

  • RWD89 Healthcare Resource Utilization and Health-Related Quality of Life in Patients With Resectable Non-Metastatic Non-Small Cell Lung Cancer Treated With Neoadjuvant Chemotherapy in China: A Real-World Survey

    Jun 1, 2024, 00:00

  • EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective

    Jun 1, 2024, 00:00

  • EE122 Analyses of Cancer Prevalence and Healthcare Costs for Metastatic and Non-Metastatic Cancers Among Employees Using Claims Data

    Jun 1, 2024, 00:00

  • HPR80 Moving Towards Inclusion: A Review of Access to Oncologic Therapies in the Light of Global Efforts to Advance Gender Equality

    Jun 1, 2024, 00:00

  • RWD31 Racial Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplant in US: A Real-World Data Study

    Jun 1, 2024, 00:00

  • HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan

    Jun 1, 2024, 00:00

  • EPH98 Association Between Social Vulnerability and Opioid Dispensing By Contiguous County in the United States

    Jun 1, 2024, 00:00

  • EPH73 Clinical Characteristics of Patients in the Intensive Care Unit with Infections Caused By Multiresistant Gram-Negative Bacteria

    Jun 1, 2024, 00:00

  • CO129 Novel Endpoints in Chronic Kidney Disease (CKD): Trends in the Use of eGFR Slope and Proteinuria As Efficacy Endpoints in Clinical Trials

    Jun 1, 2024, 00:00

  • PCR152 Can We Speak to GPT to Inform Patient Preference Studies?

    Jun 1, 2024, 00:00

  • EPH214 Impact of Preoperative Anxiety and Depression on Chronic Postoperative Opioid Use in Orthopedic Surgery Patients

    Jun 1, 2024, 00:00

  • RWD97 Real-World Disease Burden of Fibrodysplasia Ossificans Progressiva in China

    Jun 1, 2024, 00:00

  • PCR240 Medication Adherence to Direct Acting Anti-Viral Agents Among Hepatitis C Virus Infected Patients in the United States

    Jun 1, 2024, 00:00

  • SA13 Approaches to Electronic Health Records Notes Selection: Considerations for Best Practices

    Jun 1, 2024, 00:00

  • EPH67 Incidence of Mortality and the Impact of Malnutrition on Chronic Kidney Disease Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • PCR258 Work Productivity and Activity Impairment Associated with Generalized Anxiety Disorder Among Adults in the United States

    Jun 1, 2024, 00:00

  • RWD138 Evidence Gap Analysis of the Burden of Illness and Treatment of Myasthenia Gravis

    Jun 1, 2024, 00:00

  • EE173 Exploring the Financial Burden Associated with the Management of Dystrophic Epidermolysis Bullosa (DEB): A Systematic Literature Review (SLR) with Database Review of Future Disease-Modifying Therapies (DMTs)

    Jun 1, 2024, 00:00

  • PCR139 Beneficial Effect of Physical Activity on Pain-Related Self-Efficacy Among Women with Endometriosis and Chronic Pelvic Pain, Cross-Sectional Study

    Jun 1, 2024, 00:00

  • EE182 Mepolizumab Impact on Healthcare Resource Utilization and Work Productivity in Patients with Severe Asthma: REALITI-A 2-Year Analysis

    Jun 1, 2024, 00:00

  • SA34 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease - A Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE460 Theoretical Exploration of the Inclusion of Non-Traditional Multiple Sclerosis Measurement Variables on the Cost-Effectiveness of Future Treatments

    Jun 1, 2024, 00:00

  • CO37 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Clinical Outcomes of Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) in Alberta, Canada

    Jun 1, 2024, 00:00

  • EE76 Anterior-Based Muscle-Sparing Approach (ABLE) Is Cost-Effective When Compared with Posterolateral and Direct Anterior Approaches for Total Hip Arthroplasties

    Jun 1, 2024, 00:00

  • P16 Generalized Prevalence-Adjusted Willingness-to-Pay to Control for Health Equity in Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • HPR126 Monitoring Drug Volume-Based Procurement in Shanghai, China: A Data-Driven Situation Analysis

    Jun 1, 2024, 00:00

  • EE41 Economic Evaluation for the United States (US) of the Overall Survival Analysis of Cemiplimab Plus Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer (NSCLC) With at Least 50% PD-L1 Positivity

    Jun 1, 2024, 00:00

  • HPR88 Variation in State Medicaid Use of Brand-over-Generic Preferred Drug Lists

    Jun 1, 2024, 00:00

  • EPH177 Clinical and Sociodemographic Characteristics of Patients With Vitiligo in Colombia: Preliminary Results From REVIC

    Jun 1, 2024, 00:00

  • MSR89 Machine Learning-Based Approach to Discover Subtypes of Light-Chain Amyloidosis Using US Claims Data

    Jun 1, 2024, 00:00

  • HPR73 Breast Cancer-Related Healthcare Resource Utilization and Staging before and after the COVID-19 Pandemic Among White and Black Patients with Newly Diagnosed Breast Cancer

    Jun 1, 2024, 00:00

  • EE128 Customer Service Analytics Improve Health Outcomes at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • PCR106 Willingness To Pay for Temporary Alleviation of Anemia Status Transfusion-Dependent Beta-Thalassemia Patients in China

    Jun 1, 2024, 00:00

  • PCR87 Supporting Diversity and Inclusion Through the Evaluation of Differential Item Functioning (DIF) By Race and Ethnicity in the Asthma Control Questionnaire and Asthma Quality of Life Questionnaire Using Dupilumab Phase 3 Data

    Jun 1, 2024, 00:00

  • EPH153 Screening Interval for Colonoscopic Screening for Colorectal Cancer: A Systematic Review of Interval Cancer Rates of Colonoscopic Screening for Colorectal Cancer

    Jun 1, 2024, 00:00

  • CO10 Early Adoption and Utilization of Perfluorohexyloctane for Treatment of Dry Eye Disease

    Jun 1, 2024, 00:00

  • EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss

    Jun 1, 2024, 00:00

  • RWD49 Real-World Impact of Erenumab on Adherence, Work Absenteeism, and Rescue Medication Utilization Among Patients With Migraine: Results of an Outcomes-Based Agreement

    Jun 1, 2024, 00:00

  • SA2 A Unique Approach for Identifying Thoracic Endovascular Aortic Repair Stent Graft Landing Zones 0/1/2 Using Revascularization Procedure Codes from a Commercial Claims Database

    Jun 1, 2024, 00:00

  • EE412 Real-World Cost-Effectiveness Analysis of Ustekinumab-Based Therapies Vs Non-Biologic Therapies for Moderate to Severe Crohn’s Disease in Chinese Population

    Jun 1, 2024, 00:00

  • PCR125 Measuring and Valuing Health for Children: A Series of Reviews to Inform Health Technology Assessment

    Jun 1, 2024, 00:00

  • SA76 A Targeted Literature Review of Economic Evaluations, Health-Related Quality of Life, Healthcare Resource Use, and Costs Associated With Polymyalgia Rheumatica

    Jun 1, 2024, 00:00

  • EE148 The Institutional Level Impact of Additional Apheresis Days for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation on Costs and Healthcare Resource Utilization

    Jun 1, 2024, 00:00

  • SA30 Symptom Burden and Healthcare Resource Use in Claudin 18.2+ (CLDN18.2+), HER2− Patients With Locally Advanced (LA) Unresectable or Metastatic Gastric or Gastroesophageal Junction (mG/GEJ) Adenocarcinoma

    Jun 1, 2024, 00:00

  • CO130 Diagnosis, Treatment, and Control of Hypertension Among US Adults: The National Health and Nutrition Examination Survey, 2009 to 2020

    Jun 1, 2024, 00:00

  • EE45 Influential Factors on the Economic Justifiable Pri Systematic Investigation of Factors and Mechanisms Beyond the Incremental Cost Effectiveness Ratio

    Jun 1, 2024, 00:00
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18 (current)
  • 19
  • 20
  • »